EUVIMEDEUVIMED entdecken
Open Access

Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder

Ashley N Ewens, Alexander Pilski, Shayne D Hastings, Chris Krook-Magnuson, Steven M Graves, Esther Krook-Magnuson, Stanley A Thayer iD

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.124.002272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Ashley N Ewens und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota (A.N.E., A.P., S.M.G., S.A.T.); and Department of Neurosci…. Hauptthemen laut MEDLINE: Levetiracetam, Mice, Transgenic, tat Gene Products, Human Immunodeficiency Virus, Piracetam. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevetiracetamMice, Transgenictat Gene Products, Human Immunodeficiency VirusPiracetamCognitionAIDS Dementia ComplexAnimalsMiceMaleDisease Models, AnimalAnticonvulsantsHIV-1HippocampusHumansSeizuresNeuronal PlasticityMice, Inbred C57BLExcitatory Postsynaptic PotentialsSynaptic Transmission

Substanzen

Levetiracetamtat Gene Products, Human Immunodeficiency VirusPiracetamAnticonvulsants

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota (A.N.E., A.P., S.M.G., S.A.T.); and Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota (S.D.H., C.K.-M.…

ORCID-Profile: Stanley A Thayer

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Ewens, A. N., Pilski, A., Hastings, S. D., Krook-Magnuson, C., Graves, S. M., Krook-Magnuson, E., & Thayer, S. A. (2024). Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002272

Vancouver

Ewens AN, Pilski A, Hastings SD, Krook-Magnuson C, Graves SM, Krook-Magnuson E, et al. Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.124.002272

BibTeX
@article{Ewens2024,
  author = {Ewens, Ashley N and Pilski, Alexander and Hastings, Shayne D and Krook-Magnuson, Chris and Graves, Steven M and Krook-Magnuson, Esther and Thayer, Stanley A},
  title = {Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.124.002272}
}
Kostenlos starten →